VIDO-InterVac

VIDO-InterVac is a Canadian infectious disease and vaccine research institute located in Saskatoon, Saskatchewan, associated with the University of Saskatchewan. The institute conducts preclinical and translational work on pathogens affecting humans and animals and operates high-containment laboratories and a biocontainment vaccine centre. It collaborates with national and international agencies to advance vaccine candidates and infectious disease countermeasures.

History

Founded in 1975 as a veterinary infectious disease organization tied to the University of Saskatchewan, the institute evolved through national health milestones including responses to outbreaks such as the H1N1 pandemic and the COVID-19 pandemic. Its development reflects broader Canadian public health initiatives like the formation of the Public Health Agency of Canada and research investments linked to agencies such as the Canadian Institutes of Health Research. Over decades the institute expanded amid partnerships with provincial bodies like the Government of Saskatchewan and federal programs tied to the National Research Council (Canada), adapting to global events including the SARS outbreak and concerns raised during the Avian influenza episodes.

Facilities and infrastructure

The institute houses high-containment laboratories including Biosafety Level 2, Biosafety Level 3, and specialized biocontainment animal facilities, comparable in function to units at the Centers for Disease Control and Prevention and the National Microbiology Laboratory. Infrastructure includes containment animal housing, high-throughput screening platforms, and manufacturing suites for preclinical vaccine production echoing capabilities at the Walter Reed Army Institute of Research and the Pasteur Institute. It is situated near the University of Saskatchewan campus and collaborates operationally with university core facilities, provincial health laboratories such as the Saskatchewan Health Authority, and veterinary diagnostic centres like the Canadian Food Inspection Agency laboratories.

Research and programs

Research programs encompass immunology, virology, bacteriology, and zoonotic disease studies, interfacing with initiatives led by entities such as the World Health Organization, the Bill & Melinda Gates Foundation, and the Wellcome Trust. Scientific teams work on pathogen characterization, vaccine platform development, adjuvant assessment, and translational animal studies similar to work undertaken at institutions like the Johns Hopkins Bloomberg School of Public Health and the Harvard T.H. Chan School of Public Health. Programs target diseases of public health importance including respiratory viruses, coronaviruses, influenza viruses, and emerging zoonoses studied by researchers affiliated with the Canadian Food Inspection Agency, the National Institutes of Health, and provincial research networks.

Partnerships and funding

VIDO-InterVac maintains partnerships with academic institutions such as the University of Toronto, McGill University, and University of British Columbia, and collaborates with industry partners including global pharmaceutical companies and biotech firms akin to Moderna, Pfizer, and GlaxoSmithKline. Funding streams have included federal investment from initiatives tied to the Innovation, Science and Economic Development Canada portfolio, grants from the Canadian Institutes of Health Research, and provincial support from the Government of Saskatchewan. International collaboration has engaged agencies like the Coalition for Epidemic Preparedness Innovations and the Pan American Health Organization, and philanthropic contributions have come from foundations comparable to the Rockefeller Foundation.

Notable projects and contributions

Contributions include preclinical evaluation of vaccine candidates during the COVID-19 pandemic and work on veterinary vaccines impacting diseases related to bovine tuberculosis and porcine reproductive and respiratory syndrome. The institute has supported rapid vaccine testing pipelines similar to efforts at the National Institute of Allergy and Infectious Diseases and provided expertise during public health responses alongside the Public Health Agency of Canada and provincial entities. Collaborative projects have spanned international vaccine trials, technology transfer initiatives reminiscent of partnerships with organizations like the European Centre for Disease Prevention and Control and the Food and Agriculture Organization, and capacity-building efforts for low- and middle-income regions coordinated with agencies such as the United Nations Development Programme.

Category:Research institutes in Canada